Attachment, Patient Self-disclosure and Psychotherapy Outcome

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-01-01

Study Completion Date

2021-09-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study investigates whether within- and between-patient effects of attachment moderate the association between self-disclosure and psychotherapy outcome.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Participants are recruited at the University Clinic Heidelberg at the beginning of their (usually) 8-week inpatient treatment. After informed consent, patients routinely fill out weekly questionnaires on attachment, self-disclosure, and symptom severity.

This study is the first to disentangle stable, trait-like (between-person) effects of both attachment and self-disclosure from within-person changes over the course of treatment. The study investigates whether (changes in) attachment moderate the association between (changes in) self-disclosure and psychotherapy outcome.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Psychotherapy Attachment Self Disclosure Treatment Outcome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Psychotherapy

Patients receive 8 weeks of inpatient psychotherapeutic treatment. Treatment consists of individual and group psychodynamic psychotherapy, as well as an individual combination of art, music, body-oriented and relaxation therapies, which are also carried out in group settings. Treatments is provided by an interdisciplinary team of psychotherapists with a medical or psychology degree, art of music therapists, social workers, physiotherapists and specialist nurses.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients of at least 18 years of age
* treated at the inpatient unit of a hospital for psychosomatic medicine
* provided measurements of symptoms, attachment style, and self-disclosure for at least one measurement occasion

Exclusion Criteria

* bipolar, acute psychotic or substance abuse disorders

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Simone Jennissen

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ulrike Dinger, Prof

Role: STUDY_CHAIR

University Hospital Heidelberg

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Attach-Sel-2021

Identifier Type: -

Identifier Source: org_study_id